15 Sep 2021 17:30
Sistema PJSFC (SSA) Sistema PJSFC: Announcement on the acquisition of Nearmedic Group 15-Sep-2021 / 19:30 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. 15 September 2021, Moscow - Sistema PJSFC ("Sistema", the "Corporation" or, together with its subsidiaries and affiliates, the "Group") (LSE: SSA, MOEX: AFKS) announces that JSC New Investment Holdingi ("the Buyer") has acquired Nearmedic International Limited, the 100% shareholder of LLC Nearmedic Plus, LLC Nearmedic Pharma, and several other pharmaceutical, biotech, and healthcare businesses in Russia and Italy ("Nearmedic Group" or "Nearmedic") for 1 rouble ("the Transaction"). Nearmedic Group's net debt as of the closing of the Transaction was RUB 5.9bn. Sistema and the Sberbank group of companies ("Sberbank") have in equal parts provided the Buyer with RUB 1.2bn in equity financing that will go towards the partial repayment of Nearmedic's outstanding debt to Sberbank. Sistema and Sberbank have also entered into option agreements, exercisable within 3.5 years from the date of closing, enabling Sistema to buy and Sberbank to sell to Sistema its equity interest in JSC New Investment Holding, with up to RUB 2.8bn in outstanding receivables due from Nearmedic to be transferred from Sberbank to Sistema immediately upon such sale. "Nearmedic Group has growth potential that can be unlocked through restructuring and improvements in efficiency, areas precisely where Sistema has robust, proven expertise. We also have a strong track record in pharmaceuticals, healthcare and biotech, all of which are key business lines for Nearmedic. We will shortly begin implementing a turnaround plan for Nearmedic Group focused on boosting the value of the company's assets and expanding production capacities," said Sistema President Vladimir Chirakhov. Nearmedic Group consists of pharmaceutical, biotech, and medical assets. The company's core businesses are the design and production of original medications; the development, manufacturing and sale of diagnostic test kits; the supply of suites of equipment for medical laboratories; and the provision of medical and lab services. Nearmedic Group possesses production facilities in the cities of Obninsk and Mosalsk, a factory producing medical products in Italy, and a chain of multi-specialty medical clinics across Moscow, Obninsk, and Ryazan.***For further information, please visit www.sistema.com or contact:
(i) JSC New Investment Holding is jointly controlled by the Group and Sberbank, which own 50%+1 shares and 50%-1 shares in its equity, respectively. |
| ISIN: | US48122U2042 |
| Category Code: | MSCM |
| TIDM: | SSA |
| LEI Code: | 213800JSZ2UUK4QQK694 |
| Sequence No.: | 122264 |
| EQS News ID: | 1233676 |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.